Summary
BioMarker Strategies , LLC
Founded in 2007
Description
BioMarker Strategies offers SnapPath, a live tumor cell testing platform that improves the treatment of cancer.
Strengths
- Revenue growth is more steady than the industry average
Weaknesses
- BioMarker Strategies , LLC has a very small market share in their industry
- Revenue generated per employee is less than the industry average
- Revenue growth is less than the industry average
- The number of employees is not growing as fast as the industry average
- Since BioMarker Strategies , LLC was founded, the company has experienced slower revenue growth than the industry average
Annual Revenue
BioMarker Strategies , LLC's annual revenue
$3305000
Based on Kona Equity data
-
Revenue per employee
$254231
-
Variance of revenue growth
0.04
-
Annual revenue growth since founding
$194411
-
Revenue growth rate from first known quarter to current
-53.0%
Employee Count
13 employees
-
Employee growth rate from first known quarter to current
-50.0%
Executives
Greg Bertenshaw
Vice President, Research & Development
g**@biomarkerstrategies.comJorge Edwards
Research Scientist
j**@biomarkerstrategies.comJerry Parrott
CEO
j**@biomarkerstrategies.comLorraine Thelian
Senior Consultant Health Technology
l**@biomarkerstrategies.comPhone Strategies
President & Chief Executive Officer
p**@biomarkerstrategies.comWilliam Murphy
Biomedical Engineer
w**@biomarkerstrategies.comAmy James
Office Administrator
a**@biomarkerstrategies.comKristin Harwood
Office Administrator
k**@biomarkerstrategies.comGregory Botting
Scientist
g**@biomarkerstrategies.comG Score - 1
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G5 Variance of revenue growth is less than the industry average
Location
Unlock unlimited leads
Similar Companies
Key Information
- Name: BioMarker Strategies , LLC
- Category: Biotechnology
- Industry: Biotechnology Company
- SIC: 8071; 807
- NAICS: 622310; 622
See similar companies
-
By City Rockville Small Biotechnology Company in Rockville Mid-size Biotechnology Company in Rockville Biotechnology in Rockville Small Biotechnology in Rockville Mid-size Biotechnology in Rockville
-
By State MD Small companies in MD Biotechnology in MD Small Biotechnology in MD Mid-size Biotechnology in MD Small Biotechnology Company in MD Mid-size Biotechnology Company in MD
-
By Category Biotechnology Small Biotechnology Mid-size Biotechnology
-
By Industry Biotechnology Company Small Biotechnology Company Mid-size Biotechnology Company Biotechnology and Biotechnology Company
-
Firmographic data G Score of 1 Founded in 2007 SIC: 8071 SIC: 807 NAICS: 622310 NAICS: 622 #Medical Testing & Clinical Laboratories #Healthcare
Frequently Asked Questions
BioMarker Strategies , LLC's headquarters are located at 15601 Crabbs Branch Way Rockville, MD 20855.
BioMarker Strategies , LLC's official website is biomarkerstrategies.com
BioMarker Strategies , LLC's annual revenue is $3.3 M.
BioMarker Strategies , LLC's SIC: 8071; 807
BioMarker Strategies , LLC's NAICS: 622310; 622.
BioMarker Strategies , LLC has 13 employees
BioMarker Strategies , LLC is in the industry of Biotechnology.